Rights & Issues Investment Trust (RIII) Competitors GBX 2,120 -10.00 (-0.47%) As of 08/29/2025 12:46 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesBuy This Stock RIII vs. PCGH, NESF, BRFI, DIG, HEFT, FAS, BHIU, ORIT, ANII, and CHIUShould you be buying Rights & Issues Investment Trust stock or one of its competitors? The main competitors of Rights & Issues Investment Trust include Polar Capital Glb Healthcare (PCGH), NextEnergy Solar Fund (NESF), BlackRock Frontiers (BRFI), Dunedin Income Growth Investment Trust (DIG), Henderson European Focus Trust (HEFT), Fidelity Asian Values (FAS), BMO UK High Income Trust (BHIU), Octopus Renewables Infrastructure Trust (ORIT), abrdn New India Investment Trust (ANII), and CT UK High Income Trust (CHIU). These companies are all part of the "asset management" industry. Rights & Issues Investment Trust vs. Its Competitors Polar Capital Glb Healthcare NextEnergy Solar Fund BlackRock Frontiers Dunedin Income Growth Investment Trust Henderson European Focus Trust Fidelity Asian Values BMO UK High Income Trust Octopus Renewables Infrastructure Trust abrdn New India Investment Trust CT UK High Income Trust Rights & Issues Investment Trust (LON:RIII) and Polar Capital Glb Healthcare (LON:PCGH) are both small-cap financial services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment. Which has stronger valuation & earnings, RIII or PCGH? Polar Capital Glb Healthcare has lower revenue, but higher earnings than Rights & Issues Investment Trust. Polar Capital Glb Healthcare is trading at a lower price-to-earnings ratio than Rights & Issues Investment Trust, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRights & Issues Investment Trust£12.32M8.23£15.28M£2.23949.40Polar Capital Glb Healthcare-£53.48M-7.73£77.59M-£0.46-740.66 Is RIII or PCGH a better dividend stock? Rights & Issues Investment Trust pays an annual dividend of GBX 0.43 per share and has a dividend yield of 0.0%. Polar Capital Glb Healthcare pays an annual dividend of GBX 0.02 per share and has a dividend yield of 0.0%. Rights & Issues Investment Trust pays out 19.4% of its earnings in the form of a dividend. Polar Capital Glb Healthcare pays out -5.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Does the media prefer RIII or PCGH? In the previous week, Rights & Issues Investment Trust had 1 more articles in the media than Polar Capital Glb Healthcare. MarketBeat recorded 1 mentions for Rights & Issues Investment Trust and 0 mentions for Polar Capital Glb Healthcare. Rights & Issues Investment Trust's average media sentiment score of 1.34 beat Polar Capital Glb Healthcare's score of 0.00 indicating that Rights & Issues Investment Trust is being referred to more favorably in the media. Company Overall Sentiment Rights & Issues Investment Trust Positive Polar Capital Glb Healthcare Neutral Is RIII or PCGH more profitable? Rights & Issues Investment Trust has a net margin of 93.27% compared to Polar Capital Glb Healthcare's net margin of 91.60%. Polar Capital Glb Healthcare's return on equity of 16.14% beat Rights & Issues Investment Trust's return on equity.Company Net Margins Return on Equity Return on Assets Rights & Issues Investment Trust93.27% 12.60% 1.65% Polar Capital Glb Healthcare 91.60%16.14%N/A Do insiders and institutionals have more ownership in RIII or PCGH? 0.9% of Rights & Issues Investment Trust shares are owned by institutional investors. Comparatively, 5.8% of Polar Capital Glb Healthcare shares are owned by institutional investors. 21.8% of Rights & Issues Investment Trust shares are owned by insiders. Comparatively, 0.2% of Polar Capital Glb Healthcare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryRights & Issues Investment Trust beats Polar Capital Glb Healthcare on 10 of the 14 factors compared between the two stocks. Get Rights & Issues Investment Trust News Delivered to You Automatically Sign up to receive the latest news and ratings for RIII and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RIII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RIII vs. The Competition Export to ExcelMetricRights & Issues Investment TrustAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£102.78M£1.46B£6.36B£2.79BDividend Yield2.06%4.61%4.33%5.32%P/E Ratio949.404,455.061,696.845,162.55Price / Sales8.231,990.801,386.47101,256.49Price / Cash12.1160.62127.5927.93Price / Book0.821.393.736.30Net Income£15.28M£265.04M£1.23B£5.89B7 Day Performance-2.01%0.31%0.04%0.19%1 Month Performance-2.59%1.65%2.67%49.33%1 Year Performance-15.20%6.78%27.13%153.42% Rights & Issues Investment Trust Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RIIIRights & Issues Investment TrustN/AGBX 2,120-0.5%N/A-13.1%£102.78M£12.32M949.401Positive NewsPCGHPolar Capital Glb HealthcareN/AGBX 345+0.6%N/A-14.1%£416.15M£84.70M5.34N/ADividend IncreaseNESFNextEnergy Solar FundN/AGBX 70.50+1.3%N/A-16.6%£409.81M£3.35M-30.09N/ABRFIBlackRock FrontiersN/AGBX 170.99+0.4%N/A+16.0%£405.94M£96.46M6.94N/ADividend IncreaseDIGDunedin Income Growth Investment TrustN/AGBX 300flatN/A+1.4%£402.59M£40.96M11.06N/ANews CoveragePositive NewsDividend AnnouncementHEFTHenderson European Focus TrustN/AN/AN/AN/A£400.01M£79.72M537.14N/AHigh Trading VolumeFASFidelity Asian ValuesN/AGBX 572+0.7%N/A+17.3%£398.23M£22.46M34.93N/ANews CoveragePositive NewsBHIUBMO UK High Income TrustN/AN/AN/AN/A£391.68M£3.93M16,900.00N/AGap UpORITOctopus Renewables Infrastructure TrustN/AGBX 70.40-0.8%N/A-12.5%£390.93M£28.91M21.54N/APositive NewsANIIabrdn New India Investment TrustN/AGBX 803.36-0.1%N/A-1.8%£389.89M£149.92M3.34N/ANews CoveragePositive NewsInsider TradeCHIUCT UK High Income TrustN/AN/AN/AN/A£383.24M£12.28M3,677.78N/A Related Companies and Tools Related Companies PCGH Competitors NESF Competitors BRFI Competitors DIG Competitors HEFT Competitors FAS Competitors BHIU Competitors ORIT Competitors ANII Competitors CHIU Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:RIII) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rights & Issues Investment Trust Please log in to your account or sign up in order to add this asset to your watchlist. Share Rights & Issues Investment Trust With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
